Related Experiment Video
Updated: Mar 14, 2026
Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
Perspectives in neonatal and childhood arterial ischemic stroke
J Fluss1, M Dinomais2,3, M Kossorotoff4
1a Pediatric Neurology Unit, Pediatric Subspecialties Service, Children's Hospital , Geneva University Hospitals , Geneva , Switzerland.
Insights
Advances in pediatric arterial ischemic stroke (AIS) care are improving outcomes. Research focuses on understanding causes like focal cerebral arteriopathy and infections, and optimizing acute and long-term treatments for children.
Area of Science:
- Neurology
- Pediatrics
- Vascular Medicine
Background:
- Significant progress in identifying, understanding, and managing pediatric arterial ischemic stroke (AIS) has been achieved.
- Focal cerebral arteriopathy is a leading cause of childhood AIS in developed nations, with well-defined imaging features but ongoing debates on mechanisms and management.
- Neonatal stroke presents a unique opportunity for early intervention to prevent neurological disability in select cases.
Purpose of the Study:
- To review current knowledge and ongoing debates in the acute and rehabilitative care of pediatric arterial ischemic stroke.
- To discuss the role of focal cerebral arteriopathy and infectious factors in childhood AIS.
- To explore the potential and limitations of thrombolytic therapy and early intervention in neonatal stroke.
Main Methods:
- Review of recent advances in pediatric arterial ischemic stroke identification, understanding, and management.
- Analysis of current research on the mechanisms, evolution, and treatment of focal cerebral arteriopathy.
- Evaluation of case reports and studies on thrombolytic therapy in acute pediatric stroke.
- Discussion of neonatal stroke and early intervention strategies.
Main Results:
- Focal cerebral arteriopathy is a common cause of pediatric AIS, though its underlying mechanisms and optimal management remain subjects of debate.
- Thrombolytic therapy has shown anecdotal efficacy in acute pediatric stroke but faces limitations.
- Early intervention in neonatal stroke is beneficial only for a select group of neonates.
- Infectious factors are increasingly recognized as potential triggers for childhood ischemic stroke, leading to vessel wall damage.
Conclusions:
- Perinatal stroke is multifactorial and linked to cerebral palsy, while many childhood ischemic strokes may stem from infections affecting blood vessels.
- Further research is crucial for identifying risk factors in both perinatal and childhood stroke.
- Defining optimal acute and preventive therapeutic strategies is essential to reduce long-term morbidity in pediatric stroke patients.
Introduction:
Over the last decade considerable advances have been made in the identification, understanding and management of pediatric arterial ischemic stroke. Such increasing knowledge has also brought new perspectives and interrogations in the current acute and rehabilitative care of these patients. Areas covered: In developed countries, focal cerebral arteriopathy is one of the most common causes of arterial ischemic stroke in childhood and imaging features are well characterized. However, there are ongoing debates regarding its underlying mechanisms, natural evolution and proper management. The implementation of thrombolytic therapy in acute pediatric stroke has been shown to be efficient in anecdotal cases but is still limited by a number of caveats, even in large tertiary centers. Finally, neonatal stroke represents a unique circumstance of possible early intervention before the onset of any neurological disability but this appears meaningful only in a selective group of neonates. Expert commentary: While perinatal stroke, a leading cause of cerebral palsy, appears to be multifactorial, a large number of childhood ischemic stroke are probably essentially triggered by infectious factors leading to vessel wall damage. Current research is aiming at better identifying risk factors in both conditions, and to define optimal acute and preventive therapeutic strategies in order to reduce significant long-term morbidity.
